Chiun‐Sheng Huang

28.4k total citations · 4 hit papers
298 papers, 8.4k citations indexed

About

Chiun‐Sheng Huang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chiun‐Sheng Huang has authored 298 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Oncology, 94 papers in Cancer Research and 79 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chiun‐Sheng Huang's work include Breast Cancer Treatment Studies (69 papers), HER2/EGFR in Cancer Research (49 papers) and AI in cancer detection (49 papers). Chiun‐Sheng Huang is often cited by papers focused on Breast Cancer Treatment Studies (69 papers), HER2/EGFR in Cancer Research (49 papers) and AI in cancer detection (49 papers). Chiun‐Sheng Huang collaborates with scholars based in Taiwan, United States and South Korea. Chiun‐Sheng Huang's co-authors include Ruey‐Feng Chang, King‐Jen Chang, Chen‐Yang Shen, Yeun‐Chung Chang, Woo Kyung Moon, Yen‐Shen Lu, Wen‐Hung Kuo, Jeon‐Hor Chen, Ching‐Hung Lin and Yi‐Hong Chou and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Chiun‐Sheng Huang

282 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Computer-Aided Diagnosis with Deep Learning Architecture: Applications to Breast Lesions in US Images and Pulmonary Nodules in CT Scans

2016 529 citations Yeun‐Chung Chang, Chiun‐Sheng Huang et al. Scientific Reports profile →
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

2017 337 citations Sara A. Hurvitz, Miguel Martín et al. profile →
Computer‐aided diagnosis of breast ultrasound images using ensemble learning from convolutional neural networks

2020 238 citations Chiun‐Sheng Huang et al. profile →
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study

2022 204 citations Chiun‐Sheng Huang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chiun‐Sheng Huang Taiwan	47	3.3k	2.2k	2.0k	1.9k	1.7k	298	8.4k
Wei Wang China	54	1.9k 0.6×	2.5k 1.1×	1.7k 0.9×	2.9k 1.5×	640 0.4×	657	12.2k
Celine M. Vachon United States	51	4.6k 1.4×	1.4k 0.6×	2.3k 1.1×	1.5k 0.8×	2.4k 1.4×	269	9.6k
Navneet Narula United States	47	1.2k 0.4×	1.8k 0.8×	1.2k 0.6×	3.0k 1.6×	1.1k 0.7×	198	9.6k
Gary J. Whitman United States	40	1.4k 0.4×	2.4k 1.1×	2.1k 1.1×	749 0.4×	925 0.6×	266	6.2k
John E. Tomaszewski United States	51	1.5k 0.5×	935 0.4×	1.3k 0.7×	2.0k 1.1×	698 0.4×	203	9.4k
Michalis V. Karamouzis Greece	36	2.9k 0.9×	886 0.4×	1.5k 0.7×	3.0k 1.6×	812 0.5×	188	8.9k
Michael Hoffmeister Germany	59	7.8k 2.4×	1.4k 0.6×	1.7k 0.9×	2.6k 1.4×	1.2k 0.7×	379	13.3k
Iréne Esposito Germany	59	5.8k 1.8×	823 0.4×	1.9k 1.0×	3.4k 1.8×	477 0.3×	312	11.3k
Fabien Reyal France	40	2.1k 0.6×	542 0.2×	2.8k 1.4×	2.4k 1.3×	605 0.4×	218	6.5k
Roberta A. Jong Canada	32	3.7k 1.1×	3.0k 1.4×	1.7k 0.8×	331 0.2×	3.8k 2.3×	77	8.4k

Countries citing papers authored by Chiun‐Sheng Huang

Since Specialization

Citations

This map shows the geographic impact of Chiun‐Sheng Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiun‐Sheng Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiun‐Sheng Huang more than expected).

Fields of papers citing papers by Chiun‐Sheng Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiun‐Sheng Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiun‐Sheng Huang. The network helps show where Chiun‐Sheng Huang may publish in the future.

Co-authorship network of co-authors of Chiun‐Sheng Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Chiun‐Sheng Huang. A scholar is included among the top collaborators of Chiun‐Sheng Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiun‐Sheng Huang. Chiun‐Sheng Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Wen-Chi, et al.. (2025). Reassessing regional nodal radiotherapy strategies for breast cancer in the context of modern systemic treatments. Journal of the Formosan Medical Association.

Gnant, Michael, Khatijah Lim Abdullah, Frances Boyle, et al.. (2024). Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis. JMIR Formative Research. 8. e50931–e50931. 1 indexed citations

Huang, Meng‐Chuan, I‐Chun Chen, Tsu‐Nai Wang, et al.. (2023). Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in Taiwan. Nutrients. 15(18). 3900–3900. 3 indexed citations

Kuo, Sung‐Hsin, Ming‐Feng Wei, Yi‐Hsuan Lee, et al.. (2023). MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer. Cellular Oncology. 46(5). 1213–1234. 10 indexed citations

Chen, Chih‐Jung, Ting‐Hao Chen, Jason Lei, et al.. (2022). Correlation of ER, PR, and HER2 at the protein and mRNA levels in Asian patients with operable breast cancer. Bioscience Reports. 42(1). 6 indexed citations

Lin, Po‐Han, Ling‐Ming Tseng, Yi‐Hsuan Lee, et al.. (2022). Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders. Journal of the Formosan Medical Association. 121(12). 2538–2547. 11 indexed citations

Hickish, Tamas, Ajay Mehta, Mei-Ching Liu, et al.. (2022). Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial. Breast Cancer Research and Treatment. 192(3). 593–602. 9 indexed citations

Shao, Zhimin, Ling‐Ming Tseng, Chiun‐Sheng Huang, et al.. (2021). Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study. Japanese Journal of Clinical Oncology. 51(3). 345–353. 2 indexed citations

Dawood, Shaheenah, Chiun‐Sheng Huang, Shona Nag, et al.. (2020). Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: an Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitors. Current Medical Research and Opinion. 36(8). 1363–1373. 5 indexed citations

10.

Hurvitz, Sara A., Miguel Martín, Michael F. Press, et al.. (2019). Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer. Clinical Cancer Research. 26(3). 566–580. 154 indexed citations

11.

Lin, Ching‐Hung, Yoon Sim Yap, Kyung-Hun Lee, et al.. (2019). Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population. JNCI Journal of the National Cancer Institute. 111(12). 1298–1306. 82 indexed citations

12.

Bardia, Aditya, Marina Parton, Sherko Kümmel, et al.. (2018). Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial. Journal of Clinical Oncology. 36(31). 3126–3133. 55 indexed citations

13.

Lee, Chia‐Yen, et al.. (2017). Automatic Marker-free Longitudinal Infrared Image Registration by Shape Context Based Matching and Competitive Winner-guided Optimal Corresponding. Scientific Reports. 7(1). 39834–39834. 4 indexed citations

14.

Kuo, Sung‐Hsin & Chiun‐Sheng Huang. (2017). Association between radiosensitivity and molecular subtypes in patients with early-stage breast cancer and lymph node-negative status. Translational Cancer Research. 6. 1 indexed citations

15.

Lu, Yen‐Shen, Tom Wei‐Wu Chen, Ching‐Hung Lin, et al.. (2015). Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy. Clinical Cancer Research. 21(8). 1851–1858. 71 indexed citations

16.

Chen, Tom Wei‐Wu, Dwan‐Ying Chang, Shu‐Min Huang, et al.. (2013). The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines. The Breast. 22(6). 1148–1154. 5 indexed citations

17.

Azim, Hatem A., Dominique Agbor‐Tarh, Ian Bradbury, et al.. (2013). Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial. Journal of Clinical Oncology. 31(36). 4504–4511. 45 indexed citations

18.

Tsauo, Jau‐Yih, et al.. (2010). Can ICF model for patients with breast-cancer-related lymphedema predict quality of life?. Supportive Care in Cancer. 19(5). 599–604. 25 indexed citations

19.

Huang, Chiun‐Sheng, Ching‐Hung Lin, Yen‐Shen Lu, & Chen‐Yang Shen. (2010). Unique features of breast cancer in Asian women—Breast cancer in Taiwan as an example. The Journal of Steroid Biochemistry and Molecular Biology. 118(4-5). 300–303. 42 indexed citations

20.

Huang, Chiun‐Sheng, Shi‐Yi Yang, Chun‐Wen Cheng, et al.. (2004). Breast Cancer Risk Associated with Genotypic Polymorphism of Oxidative DNA Damage Repair Genes - A Multigenic Study of Base Excision Repair and Transcription-Coupled Repair in Cancer Susceptibility. 15(2). 116–136. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact